NanoMedex Pharmaceuticals

About:

NanoMedex Pharmaceuticals develops technology that enables direct dispersion or emulsification of oils or water.

Description:

Nanotechnology of Microemulsions. NanoMedex Pharmaceuticals, Inc. has developed a formulation strategy to allow drugs that are only soluble in oil to be soluble in water. To administer a drug intravenously the drug must first be dissolved in water. The NanoMedex nanotechnology formulation strategy utilizes components that encapsulate the active pharmaceutical ingredient (API) into spheres (5-30 nm) so small they allow the drug to become randomly dispersed in water and act as if the drug has dissolved in the water.

Total Funding Amount:

$500000

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Middleton, Wisconsin, United States

Founded Date:

2002-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2009-06-08

IPO Status:

Private

Industries: